In 2024, AbbVie’s presentation at the conference focused on its recent acquisitions of ImmunoGen and Cerevel. AbbVie paid ...

A new CRISPR approach can control genes without cutting DNA, opening a safer path for treating genetic diseases. A newly ...

Immune checkpoint inhibitors (ICIs) have revolutionized cancer therapy by harnessing the body's immune system to target ...

Three start-ups are aiming to create gene-edited babies. Columnist Michael Le Page has no doubt that editing our offspring ...

Explore the potential of gene therapy as a groundbreaking approach to curing diseases, beyond traditional pharmacological ...

Researchers identify stem cell–based molecular subtypes that improve prognosis prediction in colorectal cancer and support ...

Rising demand for safer gene delivery methods, rapid advancements in gene therapy research, and expanding applications in oncology and rare diseases are accelerating the non-viral gene delivery ...

Such an advancement would allow for one of the most successful non-chemo cancer treatments to be done both faster and cheaper ...

Two recent studies show the novel therapy works in people with multiple myeloma, but researchers are trying to minimize side effects ...

VV169 saw complete clearance of disseminated myeloma tumors within 28 daysAnother dataset highlights Vyriad’s work in improved vector retargeting strategies in a comparative study of three methods for ...

Researchers developed cSMRTS, an engineered mRNA that preferentially turns on therapeutic genes inside targeted cells, shown ...

Today at the San Antonio Breast Cancer Symposium (SABCS), researchers presented the initial findings from a major multi-year collaboration between the ECOG-ACRIN Cancer Research Group (ECOG-ACRIN) and ...